News tagged with trials
Swine flu vaccine must be free and safe for high uptake
Oct 28, 2009 |
not rated yet |
0
Almost half of adults surveyed in Summer 2009 in Hong Kong (45%) say they would take up free swine flu vaccination. However, this figure drops to around 1 in 7 (15%) if the price they have to pay for the vaccine reaches $HK200 ...
Recommended treatment for heart failure often underused
Oct 20, 2009 |
not rated yet |
0
Less than one-third of patients hospitalized for heart failure and participating in a quality improvement registry received a guideline-recommended treatment of heart failure, aldosterone antagonist therapy, according to ...
Centralized Review Process Markedly Expedites Approval of Cancer Clinical Trials
Oct 19, 2009 |
not rated yet |
0
(PhysOrg.com) -- A Central Institutional Review Board (CIRB) for cancer clinical trials that was created by the National Cancer Institute (NCI), part of the National Institutes of Health, in 2001 helps trials start more quickly ...
Designing drugs and their antidotes together improves patient care
Oct 04, 2009 |
5 / 5 (1) |
0
Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately - because the blood thinner and antidote were designed to work together. Researchers at Duke ...
As swine flu intensifies, US rolls out first vaccine doses
Oct 04, 2009 |
not rated yet |
0
US health authorities are hoping to contain what they say is an intensifying swine flu pandemic with a massive A(H1N1) vaccination campaign that begins this Tuesday.
3 Questions: AIDS researchers on new vaccine results
Medicine & Health / HIV & AIDS
Sep 29, 2009 |
not rated yet |
0
(PhysOrg.com) -- On Thursday, an international research team reported that a new AIDS vaccine tested in more than 16,000 volunteers in Thailand protected a small but significant minority against infection. The ...
Considering usual medical care in clinical trial design
Sep 29, 2009 |
not rated yet |
0
In this week's PLoS Medicine, Liza Dawson (National Institutes of Health) and colleagues discuss the scientific and ethical issues associated with choosing clinical trial designs when there is no consensus on what consti ...
Revolutionary drug could be new hope for adrenal cancer patients
Sep 22, 2009 |
not rated yet |
0
TGen Clinical Research Services at Scottsdale Healthcare today announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the ...
Can an over-the-counter vitamin-like substance slow the progression of Parkinson's disease?
Medicine & Health / Neuroscience
Sep 21, 2009 |
not rated yet |
3
Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, ...
National trial to test new treatment for chronic, severe indigestion
Medicine & Health / Medications
Sep 17, 2009 |
not rated yet |
0
Could medicines used for depression also treat chronic, severe indigestion? Scientists at Mayo Clinic suspect they can and, backed by funding from the National Institutes of Health (NIH), they are testing that premise in ...
Tuberculosis patients can reduce transmissability by inhaling interferon through a nebulizer
Sep 15, 2009 |
not rated yet |
0
A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the ...
Discovery leads to rapid mouse 'personalized trials' in breast cancer
Sep 04, 2009 |
not rated yet |
1
One person's breast cancer is not the same as another person's, because the gene mutations differ in each tumor. That makes it difficult to match the best therapy with the individual patient.
Cuban cancer drug undergoes rare U.S. trial
Medicine & Health / Medications
Sep 04, 2009 |
not rated yet |
0
For the first time since Fidel Castro took power in Cuba over a half-century ago, a drug developed by the Communist regime is going through clinical trials in the United States.
Some discrepancies exist between outcomes indicated in trial registration and later publications
Sep 01, 2009 |
not rated yet |
0
Comparison of the primary outcomes of registered clinical trials with their subsequent publication appears to show some discrepancies, according to a study in the September 2 issue of JAMA.
New report describes types of research conducted at academic medical centers
Sep 01, 2009 |
not rated yet |
0
A study from the Massachusetts General Hospital (MGH) Institute for Health Policy gives the first detailed look at the types of research currently being conducted within U.S. academic medical centers - medical schools and ...
